ACHC 📈 Acadia Healthcare - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00404A1097
ACHC: Psychiatric, Rehabilitation, Treatment, Recovery, Mental Health, Services
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee. Web URL: https://www.acadiahealthcare.com
Additional Sources for ACHC Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ACHC Stock Overview
| Market Cap in USD | 3,760m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception | 1994-03-04 |
ACHC Stock Ratings
| Growth 5y | 14.1% |
| Fundamental | 13.0% |
| Dividend | - |
| Rel. Strength Industry | -1070 |
| Analysts | 4.38/5 |
| Fair Price Momentum | 28.24 USD |
| Fair Price DCF | 10.64 USD |
ACHC Dividends
No Dividends PaidACHC Growth Ratios
| Growth Correlation 3m | -86.8% |
| Growth Correlation 12m | -79.2% |
| Growth Correlation 5y | 66.7% |
| CAGR 5y | 2.69% |
| CAGR/Mean DD 5y | 0.19 |
| Sharpe Ratio 12m | -1.54 |
| Alpha | -91.13 |
| Beta | 1.64 |
| Volatility | 35.69% |
| Current Volume | 4560k |
| Average Volume 20d | 1629.3k |
What is the price of ACHC stocks?
As of December 21, 2024, the stock is trading at USD 37.90 with a total of 4,560,046 shares traded.
Over the past week, the price has changed by -6.79%, over one month by -3.07%, over three months by -50.39% and over the past year by -49.91%.
As of December 21, 2024, the stock is trading at USD 37.90 with a total of 4,560,046 shares traded.
Over the past week, the price has changed by -6.79%, over one month by -3.07%, over three months by -50.39% and over the past year by -49.91%.
Is Acadia Healthcare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Acadia Healthcare is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 12.99 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACHC as of December 2024 is 28.24. This means that ACHC is currently overvalued and has a potential downside of -25.49%.
Neither. Based on ValueRay Fundamental Analyses, Acadia Healthcare is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 12.99 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACHC as of December 2024 is 28.24. This means that ACHC is currently overvalued and has a potential downside of -25.49%.
Is ACHC a buy, sell or hold?
Acadia Healthcare has received a consensus analysts rating of 4.38. Therefor, it is recommend to buy ACHC.
Acadia Healthcare has received a consensus analysts rating of 4.38. Therefor, it is recommend to buy ACHC.
- Strong Buy: 8
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecast for ACHC stock price target?
According to ValueRays Forecast Model, ACHC Acadia Healthcare will be worth about 31.2 in December 2025. The stock is currently trading at 37.90. This means that the stock has a potential downside of -17.78%.
According to ValueRays Forecast Model, ACHC Acadia Healthcare will be worth about 31.2 in December 2025. The stock is currently trading at 37.90. This means that the stock has a potential downside of -17.78%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 62.3 | 64.5% |
| Analysts Target Price | 90.1 | 137.7% |
| ValueRay Target Price | 31.2 | -17.8% |